Bleeding and survival outcomes with Impella versus IABP for left ventricular unloading during VA-ECMO: a systematic review and meta-analysis
Year: 2026
Type: article
Study designs: Systematic Review, Meta-Analysis
Abstract: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used for refractory cardiogenic shock, but retrograde aortic flow increases left ventricular (LV) afterload, impairing myocardial recovery. Adjunctive unloading strategies, including intra-aortic balloon pump (IABP) and Impella, are commonly employed, though comparative outcomes remain unclear. We performed a systematic review and meta-analysis of studies comparing Impella versus IABP for LV unloading during VA-ECMO in adults. Databases were searched through January 15, 2026. The primary outcome was clinically significant bleeding. Secondary outcomes included CNS hemorrhage, access-site bleeding, renal replacement therapy (RRT), and mortality. Random-effects models were used to calculate pooled risk ratios (RR) with 95% confidence intervals (CI). Seven retrospective studies ( n = 592; Impella 250, IABP 342) were included. 6 studies contributed data to the primary bleeding analysis (Impella N = 221; IABP n = 314). Clinically significant bleeding or author reported bleeding occurred in 58.8% of Impella-treated patients and 37.6% of IABP treated patients (RR 1.44, 95% CI 0.93–2.24; I²=90%), though not statistically significant. Impella was associated with increased CNS hemorrhage (RR 3.64, 95% CI 1.32–10.07) and access-site bleeding (RR 1.94, 95% CI 1.11–3.41). Gastrointestinal bleeding did not differ significantly between groups (RR 1.58, 95% CI 0.65–3.84), nor did Renal Replacement Therapy (RR 1.27, 95% CI 0.89–1.80). In-hospital mortality did not differ (RR 0.98, 95% CI 0.71–1.37), while pooled 30-day mortality was lower in the Impella cohorts (RR 0.79, 95% CI 0.64–0.99). Available retrospective comparative data suggest that Impella based LV unloading during VA-ECMO is associated with higher rates of selected bleeding complications, particularly CNS and access-site hemorrhage, while pooled 30-day mortality favored Impella use. All studies were retrospective with nonrandomized treatment allocation and therefore findings should be interpreted as hypothesis generating rather than causal. Prospective studies with standardized bleeding and anticoagulation reporting are needed to define the optimal unloading strategy during VA-ECMO.
Institution: Arkansas Colleges of Health Education
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: Impella, intra-aortic balloon pump, venoarterial extracorporeal membrane oxygenation, left ventricular unloading, cardiogenic shock, bleeding complications, central nervous system hemorrhage, access site bleeding, renal replacement therapy, in-hospital mortality, mechanical circulatory support
Open Access status: gold
Estimated APC paid: $2,890
OpenAlex ID: W7235070392
